LIVI, RICCARDO
 Distribuzione geografica
Continente #
NA - Nord America 736
EU - Europa 391
AS - Asia 89
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.219
Nazione #
US - Stati Uniti d'America 734
PL - Polonia 128
SE - Svezia 112
IE - Irlanda 72
HK - Hong Kong 50
DE - Germania 19
IT - Italia 19
FI - Finlandia 17
TR - Turchia 16
CN - Cina 12
GB - Regno Unito 9
UA - Ucraina 9
JO - Giordania 5
SG - Singapore 3
BE - Belgio 2
CA - Canada 2
HR - Croazia 2
VN - Vietnam 2
EU - Europa 1
FR - Francia 1
IN - India 1
NL - Olanda 1
NZ - Nuova Zelanda 1
SC - Seychelles 1
Totale 1.219
Città #
Warsaw 128
Chandler 120
Fairfield 92
Dublin 71
Ashburn 50
Cambridge 50
Woodbridge 46
Seattle 40
Jacksonville 38
Houston 37
Hong Kong 33
Wilmington 33
Ann Arbor 29
Buffalo 17
Princeton 17
Izmir 16
Boston 14
Boardman 13
Altamura 10
Lawrence 10
Medford 8
Norwalk 8
San Diego 8
Beijing 7
Shanghai 5
New York 4
Andover 3
San Mateo 3
Singapore 3
Brussels 2
Dong Ket 2
Florence 2
Gainesville 2
Tappahannock 2
Toronto 2
Zagreb 2
Auburn Hills 1
Auckland 1
Bremen 1
Chicago 1
Dundalk 1
Kilburn 1
London 1
Los Angeles 1
Milan 1
New Haven 1
Totale 937
Nome #
Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritis. 182
Therapeutic challenges for systemic sclerosis: facts and future targets. 82
Renal functional reserve is impaired in patients with systemic sclerosis without clinical signs of kidney involvement. 78
Incidence and characteristics of asymptomatic distal deep vein thrombosis unexpectedly found at admission in an Internal Medicine setting 78
Valutazione circadiana dell’ attività fibrinolitica circolante nella Sclerosi Sistemica. 78
Reproducibility of ambulatory blood pressure monitoring results in pregnancy. 77
Exercise Doppler echocardiography identifies preclinic asymptomatic pulmonary hypertension in systemic sclerosis. 77
Therapeutic challenges for systemic sclerosis: facts and future targets. 75
Lack of activation of renal functional reserve predicts the risk of significant renal involvement in systemic sclerosis. 74
Systemic amyloidosis: a challenge for the rheumatologist. 73
Simultaneous and sequential same-arm measurements in the validation studies of automated blood pressure (BP) measuring devices. 65
Circulating levels of Nepsilon-(carboxymethyl)lysine are increased in systemic sclerosis. 65
Accelerated (malignant) hypertension: a study of 121 cases between 1974 and 1996. 50
Melatonin is a safe and effective treatment for chronic pulmonary and extrapulmonary sarciodosis 49
The loss of endothelium dependent vascular tone control in systemic sclerosis. 47
Hypertensive vascular crisis secondary to chronic total renal artery occlusion. 39
Gold salts and somatostatin: a new combined analgesic treatment for psoriatic arthritis. 31
Totale 1.220
Categoria #
all - tutte 3.295
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.295


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019119 0 0 0 0 0 0 0 0 0 20 60 39
2019/2020207 16 14 6 20 26 23 22 27 23 9 19 2
2020/2021174 18 11 23 8 5 24 5 12 15 20 12 21
2021/2022132 10 18 6 4 2 3 7 6 3 3 37 33
2022/2023351 30 62 10 44 26 63 44 21 38 4 5 4
2023/2024102 4 15 18 3 6 10 6 38 1 1 0 0
Totale 1.220